Tariquidar is a P-glycoprotein inhibitor undergoing research as an adjuvant against multidrug resistance in cancer. Tariquidar non-competitively binds to the p-glycoprotein transporter, thereby inhibiting transmembrane transport of anticancer drugs.

625375-84-0

C40H46N4O12S2

1695.9

XR-9576;XR9576;D 06008;D06008;XR 9576;Tariquidar dimesilate;Tariquidar dimesylate

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years